ArticleTherapeutic advances in medical oncology2024

Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L).

Yuichi Ozawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.